__NUXT_JSONP__("/drugs/Toremifene_Citrate", (function(a,b,c,d,e,f){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[{brand:c,indication:d,manufacturer:"MSN LABORATORIES PRIVATE LIMITED",splSetId:"0b3ebaa6-9cbe-405e-8f14-14ce8dcd2a68"},{brand:e,indication:"1 INDICATIONS AND USAGE FARESTON® is an estrogen agonist\u002Fantagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors. FARESTON® is an estrogen agonist\u002Fantagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors. ( 1 )",manufacturer:"KYOWA KIRIN, INC,",splSetId:"2cab8dd1-3a10-48e6-86ce-0e5275ed49e5"},{brand:a,indication:"1 INDICATIONS AND USAGE Toremifene citrate tablets are an estrogen agonist\u002Fantagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors. Toremifene citrate tablets are an estrogen agonist\u002Fantagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors.(1)",manufacturer:"Rising Pharmaceuticals, Inc.",splSetId:"dbde10d5-c689-428f-841d-b34aa5addf2d"},{brand:c,indication:d,manufacturer:"Novadoz Pharmaceuticals LLC",splSetId:"e897546b-4136-4cb5-a262-d94cf3fa3298"}],id:b,nciThesaurus:{casRegistry:"89778-27-8",chebiId:"",chemicalFormula:"C26H28ClNO.C6H8O7",definition:"The citrate salt of a nonsteroidal triphenylethylene antiestrogen.  Chemically related to tamoxifen, toremifene is a selective estrogen receptor modulator (SERM).  This agent binds competitively to estrogen receptors, thereby interfering with estrogen activity.  Toremifene also has intrinsic estrogenic properties, which is manifested depending on the tissue or species.",fdaUniiCode:"2498Y783QT",identifier:"C1756",preferredName:a,semanticType:"Organic Chemical",subclassOf:["C1821"],synonyms:["(Z)-2-[4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine 2-Hydroxy-1,2,3-propanetricarboxylate (1:1)","2-(p-[(Z)-4-chloro-1,2-diphenyl-1-butenyl]-phenoxy)- N,N-dimethylethylamine citrate (1:1)","Acapodene","FC-1157a",e,"GTx-006","TOREMIFENE CITRATE",a,"Toremifene citrate"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FToremifene_Citrate",extension:".json",createdAt:f,updatedAt:f}}],fetch:{},mutations:void 0}}("Toremifene Citrate","Toremifene_Citrate","toremifene citrate","1 INDICATIONS AND USAGE Toremifene citrate tablets are estrogen agonist\u002Fantagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors. Toremifene citrate tablets are estrogen agonist\u002Fantagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors.","Fareston","2021-10-30T13:36:25.313Z")));